Human and murine cathepsin G (CTSG) and migration inhibitory factor-related protein 8 (MRP8, also known as S100A8) are the most commonly used promoters to develop APL transgenic mouse models. This evidence concerns the gene CTSG and acute promyelocytic leukemia.